101 – 110 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Multidimensional transcriptomics provides detailed information about immune cell distribution an identity in HER2+ breast tumors
Salmén, Fredrik ; Vickovic, Sanja ; Larsson, Ludvig ; Stenbeck, Linnea ; Vallon-Christersson, Johan LU
; Ehinger, Anna
LU
; Häkkinen, Jari
LU
; Borg, Åke
LU
; Frisén, Jonas
and Stahl, Patrik
, et al.
(2018)
In BioRxiv
- Working paper/Preprint › Preprint in preprint archive
-
Mark
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
Jansson, Sara LU ; Aaltonen, Kristina LU
; Bendahl, Pär Ola
LU
; Falck, Anna Karin
LU
; Karlsson, Maria
; Pietras, Kristian
LU
and Rydén, Lisa
LU
(2018)
In Breast Cancer Research and Treatment
169(2).
p.231-241
- Contribution to journal › Article
-
Mark
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
Larsson, Anna Maria LU ; Jansson, Sara LU ; Bendahl, Pär Ola LU ; Levin Tykjaer Jörgensen, Charlotte LU ; Loman, Niklas LU ; Graffman, Cecilia LU ; Lundgren, Lotta LU ; Aaltonen, Kristina LU
and Rydén, Lisa
LU
(2018)
In Breast Cancer Research
20(1).
p.1-14
- Contribution to journal › Article
-
Mark
Nationellt Kvalitetsregister för Bröstcancer (NKBC) : Sammanfattning och vägledning till interaktiva rapporter för 2017
Ehinger, Anna LU
; Fredriksson, Irma
; Iiristo, Mariann
; Petersson, Lena-Marie
; Sandelin, Kerstin
; Asterkvist, Annette
; Grönlund, Lena
; Lövrot, John
and Oddestad, Ann-Sofi
(2018)
- Book/Report › Report
-
Mark
High-throughput molecular techniques and personalized treatment for primary breast cancer
(2018)
- Thesis › Doctoral thesis (compilation)
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
Kimbung, Siker LU ; Markholm, Ida ; Bjöhle, Judith ; Lekberg, Tobias ; Wachenfeldt, von Anna ; Azavedo, Edward ; Saracco, Ariel ; Hellström, Mats ; Veerla, Srinivas LU
and Paquet, Eric
, et al.
(2018)
In International Journal of Cancer
142(3).
p.618-628
- Contribution to journal › Article
-
Mark
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
Rydén, Lisa LU
; Loman, Niklas
LU
; Larsson, Christer
LU
; Hegardt, Cecilia
LU
; Vallon-Christersson, Johan
LU
; Malmberg, Martin
; Lindman, Henrik
; Ehinger, Anna
LU
; Saal, Lao H.
LU
and Borg, Åke
LU
(2018)
In British Journal of Surgery
105(2).
p.158-168
- Contribution to journal › Article
-
Mark
Surface guided radiotherapy increases setup accuracy for locoregional breast cancer patients
Mannerberg, Annika LU ; Kügele, Malin LU
; Berg, L.
; Edvardsson, Anneli
LU
; Alkner, Sara
LU
and Ceberg, Sofie
LU
(2018)
ESTRO 37
In Radiotherapy and Oncology
127(Suppl 1).
p.1122-1122
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial
Sjöström, Martin LU ; Lundstedt, Dan ; Hartman, Linda LU
; Holmberg, Erik
; Killander, Fredrika
LU
; Kovács, Anikó
; Malmström, Per
LU
; Niméus, Emma
LU
; Rönnerman, Elisabeth Werner
and Fernö, Mårten
LU
, et al.
(2017)
In Journal of Clinical Oncology
35(28).
p.3222-3229
- Contribution to journal › Article
-
Mark
Nationellt Kvalitetsregister för Bröstcancer (NKBC) : Sammanfattning och vägledning till interaktiva rapporter för 2016
Ehinger, Anna LU
; Iiristo, Mariann
; Löfgren, Lars
; Petersson, Lena-Marie
and Sandelin, Kerstin
(2017)
- Book/Report › Report